St. Petersburg Mechnikov State Medical Academy Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00334386
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

North-Western State Medical University named after I.I.Mechnikov | North-West State Medical University named after I.I. Mechnikov | St.Petersburg Mechnikov State Medical Academy North-West Center of Arrhythmia Diagnostics and Treatment, St. Petesburg, Russia

Active Ingredients

Drugs in Phase 4 Trials (1)

torsemide (demadex) (1 trial)

Drugs in Phase 3 Trials (5)

inosine (2 trials)

methionine (2 trials)

nicotinamide (2 trials)

ringer's lactate (2 trials)

sodium succinate (2 trials)

Drugs in Phase 2 Trials (1)

interferon gamma-1b (actimmune) (1 trial)

Drugs in Other Trials (2)

chondroitin (1 trial)

glucosamine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Jaundice (Phase 3)

Jaundice, Obstructive (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 9